NO308739B1 - Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme - Google Patents
Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende sammeInfo
- Publication number
- NO308739B1 NO308739B1 NO971306A NO971306A NO308739B1 NO 308739 B1 NO308739 B1 NO 308739B1 NO 971306 A NO971306 A NO 971306A NO 971306 A NO971306 A NO 971306A NO 308739 B1 NO308739 B1 NO 308739B1
- Authority
- NO
- Norway
- Prior art keywords
- composition
- alkyl
- hiv
- well
- same
- Prior art date
Links
- 150000002460 imidazoles Chemical class 0.000 title abstract 2
- 230000036436 anti-hiv Effects 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000006823 (C1-C6) acyl group Chemical group 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- -1 hydroxyiminomethyl Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25749094 | 1994-09-26 | ||
| JP8469095 | 1995-03-15 | ||
| JP22720595 | 1995-08-12 | ||
| PCT/JP1995/001936 WO1996010019A1 (en) | 1994-09-26 | 1995-09-25 | Imidazole derivative |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO971306D0 NO971306D0 (no) | 1997-03-20 |
| NO971306L NO971306L (no) | 1997-05-21 |
| NO308739B1 true NO308739B1 (no) | 2000-10-23 |
Family
ID=27304632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO971306A NO308739B1 (no) | 1994-09-26 | 1997-03-20 | Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US5910506A (no) |
| EP (1) | EP0786455B1 (no) |
| JP (1) | JP3155009B2 (no) |
| KR (1) | KR100387157B1 (no) |
| CN (1) | CN1093535C (no) |
| AT (1) | ATE255564T1 (no) |
| BR (1) | BR9509024A (no) |
| CA (1) | CA2200316C (no) |
| DE (1) | DE69532245T2 (no) |
| DK (1) | DK0786455T3 (no) |
| ES (1) | ES2211917T3 (no) |
| FI (1) | FI971234L (no) |
| HU (1) | HUT77357A (no) |
| MX (1) | MX9702030A (no) |
| NO (1) | NO308739B1 (no) |
| PL (1) | PL183931B1 (no) |
| PT (1) | PT786455E (no) |
| RU (1) | RU2157368C2 (no) |
| TW (1) | TW401404B (no) |
| WO (1) | WO1996010019A1 (no) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0893442B1 (en) * | 1996-03-28 | 2005-01-12 | Shionogi & Co., Ltd. | Lymph-absorbable imidazole derivatives |
| EP0906756A4 (en) * | 1996-04-04 | 2000-11-22 | Shionogi & Co | ANTI-HIV COMPOSITION CONTAINING IMIDAZOLE DERIVATIVE |
| RU2188821C2 (ru) * | 1996-12-26 | 2002-09-10 | Сионоги Энд Ко., Лтд. | Способ получения производных имидазола |
| EP0994106B1 (en) * | 1996-12-26 | 2004-03-17 | Shionogi & Co., Ltd. | Process for the preparation of carbamoylated imidazole derivatives |
| TWI232214B (en) * | 1998-04-16 | 2005-05-11 | Shionogi & Co | Preparation of aryl sulfenyl halide |
| EP1172097B1 (en) | 1999-04-12 | 2004-09-08 | Shionogi & Co., Ltd. | Process for producing medicinal composition of a basic hydrophobic medicinal compound |
| GB0016787D0 (en) * | 2000-07-07 | 2000-08-30 | Pfizer Ltd | Compounds useful in therapy |
| KR100567706B1 (ko) | 2001-01-31 | 2006-04-05 | 워너-램버트 캄파니 엘엘씨 | 알코올의 카르바모일화 방법 |
| ES2376998T3 (es) | 2001-02-23 | 2012-03-21 | K.U. Leuven Research And Development | Derivados de N-aminoimidazol inhibidores de HIV |
| SK287858B6 (sk) | 2001-04-10 | 2012-01-04 | Pfizer Inc. | Pyrazole derivatives and their use and pharmaceutical compositions containing them |
| GB0113524D0 (en) | 2001-06-04 | 2001-07-25 | Hoffmann La Roche | Pyrazole derivatives |
| CN101041669A (zh) | 2002-04-26 | 2007-09-26 | 吉里德科学公司 | 非核苷逆转录酶抑制剂 |
| TW200423930A (en) | 2003-02-18 | 2004-11-16 | Hoffmann La Roche | Non-nucleoside reverse transcriptase inhibitors |
| MXPA05010081A (es) | 2003-03-24 | 2005-11-23 | Hoffmann La Roche | Bencil-piridazinonas como inhibidores de transcriptasa inversa. |
| EP1628685B1 (en) | 2003-04-25 | 2010-12-08 | Gilead Sciences, Inc. | Antiviral phosphonate analogs |
| US7407965B2 (en) | 2003-04-25 | 2008-08-05 | Gilead Sciences, Inc. | Phosphonate analogs for treating metabolic diseases |
| US7427636B2 (en) | 2003-04-25 | 2008-09-23 | Gilead Sciences, Inc. | Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| EA200501676A1 (ru) | 2003-04-25 | 2006-04-28 | Джилид Сайэнс, Инк. | Фосфонатсодержащие ингибиторы киназы (варианты), способ их получения, фармацевтическая композиция, лекарственная форма на их основе и способ ингибирования киназы у млекопитающего (варианты) |
| US7300924B2 (en) | 2003-04-25 | 2007-11-27 | Gilead Sciences, Inc. | Anti-infective phosphonate analogs |
| WO2005002626A2 (en) | 2003-04-25 | 2005-01-13 | Gilead Sciences, Inc. | Therapeutic phosphonate compounds |
| US7470724B2 (en) | 2003-04-25 | 2008-12-30 | Gilead Sciences, Inc. | Phosphonate compounds having immuno-modulatory activity |
| US7452901B2 (en) | 2003-04-25 | 2008-11-18 | Gilead Sciences, Inc. | Anti-cancer phosphonate analogs |
| US7432261B2 (en) | 2003-04-25 | 2008-10-07 | Gilead Sciences, Inc. | Anti-inflammatory phosphonate compounds |
| WO2005016912A1 (en) * | 2003-08-19 | 2005-02-24 | Pfizer Inc. | An efficient microbial preparation of capravirine metabolites m4 and m5 |
| US7432273B2 (en) | 2003-10-24 | 2008-10-07 | Gilead Sciences, Inc. | Phosphonate analogs of antimetabolites |
| JP2007508843A (ja) | 2003-10-24 | 2007-04-12 | ギリアード サイエンシーズ， インコーポレイテッド | 治療用化合物の同定のための方法および組成物 |
| WO2005044279A1 (en) | 2003-10-24 | 2005-05-19 | Gilead Sciences, Inc. | Purine nucleoside phosphonate conjugates |
| US7432272B2 (en) | 2003-12-22 | 2008-10-07 | Gilead Sciences, Inc. | Antiviral analogs |
| US20080132549A1 (en) * | 2004-04-14 | 2008-06-05 | Pfizer Inc. | Sulphur-Linked Imidazone Compounds for the Treatment of Hiv/Aids |
| CN101027062A (zh) | 2004-07-27 | 2007-08-29 | 吉里德科学公司 | Hiv抑制剂化合物的膦酸酯类似物 |
| WO2006013948A1 (ja) * | 2004-08-04 | 2006-02-09 | Taisho Pharmaceutical Co., Ltd. | トリアゾール誘導体 |
| JP2008526828A (ja) * | 2005-01-06 | 2008-07-24 | ファイザー・リミテッド | 逆転写酵素モジュレーターとしてのイミダゾール誘導体 |
| KR20100129331A (ko) * | 2005-12-01 | 2010-12-08 | 에프. 호프만-라 로슈 아게 | 항암제로서 사용하기 위한 ｐ53 및 ｍｄｍ2 단백질 간 상호작용의 저해제로서의 2,4,5-트리페닐 이미다졸린 유도체 |
| US8022091B2 (en) | 2006-02-03 | 2011-09-20 | Taisho Pharmaceutical Co., Ltd. | Triazole derivative |
| JP5218737B2 (ja) * | 2006-02-06 | 2013-06-26 | 大正製薬株式会社 | スフィンゴシン−１−リン酸結合阻害物質 |
| US7649098B2 (en) * | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
| JP5207964B2 (ja) | 2006-03-31 | 2013-06-12 | 武田薬品工業株式会社 | 酸分泌抑制薬 |
| KR101401811B1 (ko) | 2006-08-16 | 2014-05-29 | 에프. 호프만-라 로슈 아게 | 비-뉴클레오사이드 역전사효소 저해제 |
| SI2177512T1 (sl) | 2007-08-01 | 2012-06-29 | Taisho Pharmaceutical Co Ltd | Inhibitor vezave S1P1 |
| TW200920355A (en) * | 2007-09-06 | 2009-05-16 | Lexicon Pharmaceuticals Inc | Compositions and methods for treating immunological and inflammatory diseases and disorders |
| JP5345140B2 (ja) * | 2007-09-28 | 2013-11-20 | 武田薬品工業株式会社 | プロトンポンプ阻害剤としての５員複素環化合物 |
| CA2709348C (en) | 2007-12-21 | 2016-07-19 | F. Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors for treating human immunodeficiency virus (hiv-1) mediated diseases |
| MX2011000306A (es) | 2008-07-08 | 2011-03-15 | Gilead Sciences Inc | Sales de compuestos inhibidores de hiv. |
| US8785488B2 (en) | 2009-02-12 | 2014-07-22 | Exelixis Patent Company Llc | Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity |
| CN102448953B (zh) | 2009-03-26 | 2014-05-07 | 武田药品工业株式会社 | 吡唑化合物 |
| EP2508511A1 (en) | 2011-04-07 | 2012-10-10 | Laboratoire Biodim | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| PL2890684T3 (pl) * | 2012-07-24 | 2018-08-31 | Bial-Portela & Ca, S.A. | Związki mocznikowe i ich zastosowanie jako inhibitorów enzymu |
| EP2716639A1 (en) | 2012-10-05 | 2014-04-09 | Laboratoire Biodim | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| EP2716632A1 (en) | 2012-10-05 | 2014-04-09 | Laboratoire Biodim | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| GB201602934D0 (en) | 2016-02-19 | 2016-04-06 | Cancer Res Inst Royal | Compounds |
| EP3381905A1 (en) * | 2017-03-30 | 2018-10-03 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Novel antiviral compounds |
| ES2969496T3 (es) | 2017-08-01 | 2024-05-20 | Gilead Sciences Inc | Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2- il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63150266A (ja) * | 1986-12-12 | 1988-06-22 | Mitsui Petrochem Ind Ltd | ベンジルイミダゾ−ル誘導体 |
| JPH0283373A (ja) * | 1988-05-19 | 1990-03-23 | Nippon Soda Co Ltd | ５員環の複素環化合物及びその製造方法 |
| IL98319A (en) * | 1990-07-05 | 1997-04-15 | Roussel Uclaf | Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them |
| TW235963B (no) * | 1992-01-16 | 1994-12-11 | Shionogi & Co | |
| DE10230797C2 (de) * | 2001-07-16 | 2003-09-25 | Dieter Reif | Befestigungsklammer zur Verbindung von Holzbauteilen |
-
1995
- 1995-09-25 CN CN95195260A patent/CN1093535C/zh not_active Expired - Fee Related
- 1995-09-25 PT PT95932231T patent/PT786455E/pt unknown
- 1995-09-25 DE DE69532245T patent/DE69532245T2/de not_active Expired - Fee Related
- 1995-09-25 ES ES95932231T patent/ES2211917T3/es not_active Expired - Lifetime
- 1995-09-25 WO PCT/JP1995/001936 patent/WO1996010019A1/ja active IP Right Grant
- 1995-09-25 EP EP95932231A patent/EP0786455B1/en not_active Expired - Lifetime
- 1995-09-25 RU RU97106829/04A patent/RU2157368C2/ru not_active IP Right Cessation
- 1995-09-25 AT AT95932231T patent/ATE255564T1/de not_active IP Right Cessation
- 1995-09-25 JP JP51159896A patent/JP3155009B2/ja not_active Expired - Fee Related
- 1995-09-25 MX MX9702030A patent/MX9702030A/es not_active IP Right Cessation
- 1995-09-25 HU HU9701899A patent/HUT77357A/hu not_active Application Discontinuation
- 1995-09-25 CA CA002200316A patent/CA2200316C/en not_active Expired - Fee Related
- 1995-09-25 DK DK95932231T patent/DK0786455T3/da active
- 1995-09-25 PL PL95320009A patent/PL183931B1/pl not_active IP Right Cessation
- 1995-09-25 BR BR9509024A patent/BR9509024A/pt not_active IP Right Cessation
- 1995-09-25 KR KR1019970701989A patent/KR100387157B1/ko not_active Expired - Fee Related
- 1995-09-25 US US08/809,624 patent/US5910506A/en not_active Expired - Fee Related
- 1995-09-29 TW TW084110183A patent/TW401404B/zh not_active IP Right Cessation
-
1997
- 1997-03-20 NO NO971306A patent/NO308739B1/no unknown
- 1997-03-25 FI FI971234A patent/FI971234L/fi unknown
-
1998
- 1998-12-04 US US09/205,289 patent/US6147097A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3155009B2 (ja) | 2001-04-09 |
| FI971234L (fi) | 1997-05-23 |
| HUT77357A (hu) | 1998-03-30 |
| EP0786455B1 (en) | 2003-12-03 |
| DE69532245T2 (de) | 2004-09-16 |
| CA2200316C (en) | 2004-09-21 |
| ES2211917T3 (es) | 2004-07-16 |
| MX9702030A (es) | 1997-06-28 |
| PL183931B1 (pl) | 2002-08-30 |
| AU4788896A (en) | 1996-04-19 |
| ATE255564T1 (de) | 2003-12-15 |
| RU2157368C2 (ru) | 2000-10-10 |
| PL320009A1 (en) | 1997-09-01 |
| NO971306D0 (no) | 1997-03-20 |
| US6147097A (en) | 2000-11-14 |
| AU706095B2 (en) | 1999-06-10 |
| CN1093535C (zh) | 2002-10-30 |
| BR9509024A (pt) | 1997-09-30 |
| CA2200316A1 (en) | 1996-04-04 |
| CN1158609A (zh) | 1997-09-03 |
| FI971234A0 (fi) | 1997-03-25 |
| DE69532245D1 (en) | 2004-01-15 |
| NO971306L (no) | 1997-05-21 |
| US5910506A (en) | 1999-06-08 |
| KR100387157B1 (ko) | 2003-09-29 |
| KR970706260A (ko) | 1997-11-03 |
| EP0786455A1 (en) | 1997-07-30 |
| PT786455E (pt) | 2004-02-27 |
| WO1996010019A1 (en) | 1996-04-04 |
| TW401404B (en) | 2000-08-11 |
| DK0786455T3 (da) | 2004-03-29 |
| EP0786455A4 (en) | 1998-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO308739B1 (no) | Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme | |
| NO179142C (no) | 3-benzyliden-1-karbamoyl-2-pyrrolidon-analoger | |
| ID29452A (id) | 4-okso-1,4-dihidro-3-quinolinkarboksamida sebagai agen-agen antivirus | |
| FI952101A0 (fi) | Merkaptanfoerening | |
| DE69013959D1 (de) | Aminobenzolsulfonsäurederivate. | |
| ES2093091T3 (es) | Derivado de glutation. | |
| FI884088A0 (fi) | Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat. | |
| ATE113030T1 (de) | Hydroxyalkancarbonsäure-derivate und deren verwendung. | |
| FI904728A0 (fi) | Benzanilider. | |
| EP0785190A3 (no) | ||
| DK0594329T3 (da) | Antimikrobielle midler, der omfatter polykvaternære ammoniumforbindelser | |
| DK0676399T3 (da) | Methotrexaderivater | |
| DK0420224T3 (da) | Anthihepatopatisk middel | |
| DE60026161D1 (de) | Amidin-derivate, ihre herstellung und verwendung als medikamenten | |
| BR9305092A (pt) | Processo para a preparação de derivados de 5-pirazolmercáptan, composto ditiocarbazato de etilideno, processo para a preparação de derivados do mesmo | |
| ATE126504T1 (de) | 1-phenoxycarbonyl-2-pyrrolidon-derivate und nootrope wirkstoffe. | |
| ATE125790T1 (de) | N-fumaramidsäurederivate und diese enthaltende fungizide. |